The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages

Interleukin-10 (IL-10) is a key anti-inflammatory cytokine, secreted by macrophages and other immune cells to attenuate inflammation. Autocrine type I interferons (IFNs) largely mediate the delayed expression of IL-10 by LPS-stimulated macrophages. We have previously shown that IL-10 is synergistica...

Full description

Saved in:
Bibliographic Details
Main Authors: Orna Ernst, Yifat Glucksam-Galnoy, Muhammad Athamna, Iris Ben-Dror, Hadar Ben-Arosh, Galit Levy-Rimler, Iain D. C. Fraser, Tsaffrir Zor
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/3451461
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552787661029376
author Orna Ernst
Yifat Glucksam-Galnoy
Muhammad Athamna
Iris Ben-Dror
Hadar Ben-Arosh
Galit Levy-Rimler
Iain D. C. Fraser
Tsaffrir Zor
author_facet Orna Ernst
Yifat Glucksam-Galnoy
Muhammad Athamna
Iris Ben-Dror
Hadar Ben-Arosh
Galit Levy-Rimler
Iain D. C. Fraser
Tsaffrir Zor
author_sort Orna Ernst
collection DOAJ
description Interleukin-10 (IL-10) is a key anti-inflammatory cytokine, secreted by macrophages and other immune cells to attenuate inflammation. Autocrine type I interferons (IFNs) largely mediate the delayed expression of IL-10 by LPS-stimulated macrophages. We have previously shown that IL-10 is synergistically expressed in macrophages following a costimulus of a TLR agonist and cAMP. We now show that the cAMP pathway directly upregulates IL-10 transcription and plays an important permissive and synergistic role in early, but not late, LPS-stimulated IL-10 mRNA and protein expression in mouse macrophages and in a mouse septic shock model. Our results suggest that the loss of synergism is not due to desensitization of the cAMP inducing signal, and it is not mediated by a positive crosstalk between the cAMP and type I IFN pathways. First, cAMP elevation in LPS-treated cells decreased the secretion of type I IFN. Second, autocrine/paracrine type I IFNs induce IL-10 promoter reporter activity only additively, but not synergistically, with the cAMP pathway. IL-10 promoter reporter activity was synergistically induced by cAMP elevation in macrophages stimulated by an agonist of either TLR4, TLR2/6, or TLR7, receptors which signal via MyD88, but not by an agonist of TLR3 which signals independently of MyD88. Moreover, MyD88 knockout largely reduced the synergistic IL-10 expression, indicating that MyD88 is required for the synergism displayed by LPS with cAMP. This report delineates the temporal regulation of early cAMP-accelerated vs. late type I IFN-dependent IL-10 transcription in LPS-stimulated murine macrophages that can limit inflammation at its onset.
format Article
id doaj-art-886b6554b65c4643a00abb21d2041f34
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-886b6554b65c4643a00abb21d2041f342025-02-03T05:57:49ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/34514613451461The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse MacrophagesOrna Ernst0Yifat Glucksam-Galnoy1Muhammad Athamna2Iris Ben-Dror3Hadar Ben-Arosh4Galit Levy-Rimler5Iain D. C. Fraser6Tsaffrir Zor7Department of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelSignaling Systems Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892 MD, USADepartment of Biochemistry & Molecular Biology, School of Neurobiology, Biochemistry & Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv 69978, IsraelInterleukin-10 (IL-10) is a key anti-inflammatory cytokine, secreted by macrophages and other immune cells to attenuate inflammation. Autocrine type I interferons (IFNs) largely mediate the delayed expression of IL-10 by LPS-stimulated macrophages. We have previously shown that IL-10 is synergistically expressed in macrophages following a costimulus of a TLR agonist and cAMP. We now show that the cAMP pathway directly upregulates IL-10 transcription and plays an important permissive and synergistic role in early, but not late, LPS-stimulated IL-10 mRNA and protein expression in mouse macrophages and in a mouse septic shock model. Our results suggest that the loss of synergism is not due to desensitization of the cAMP inducing signal, and it is not mediated by a positive crosstalk between the cAMP and type I IFN pathways. First, cAMP elevation in LPS-treated cells decreased the secretion of type I IFN. Second, autocrine/paracrine type I IFNs induce IL-10 promoter reporter activity only additively, but not synergistically, with the cAMP pathway. IL-10 promoter reporter activity was synergistically induced by cAMP elevation in macrophages stimulated by an agonist of either TLR4, TLR2/6, or TLR7, receptors which signal via MyD88, but not by an agonist of TLR3 which signals independently of MyD88. Moreover, MyD88 knockout largely reduced the synergistic IL-10 expression, indicating that MyD88 is required for the synergism displayed by LPS with cAMP. This report delineates the temporal regulation of early cAMP-accelerated vs. late type I IFN-dependent IL-10 transcription in LPS-stimulated murine macrophages that can limit inflammation at its onset.http://dx.doi.org/10.1155/2019/3451461
spellingShingle Orna Ernst
Yifat Glucksam-Galnoy
Muhammad Athamna
Iris Ben-Dror
Hadar Ben-Arosh
Galit Levy-Rimler
Iain D. C. Fraser
Tsaffrir Zor
The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages
Mediators of Inflammation
title The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages
title_full The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages
title_fullStr The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages
title_full_unstemmed The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages
title_short The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages
title_sort camp pathway amplifies early myd88 dependent and type i interferon independent lps induced interleukin 10 expression in mouse macrophages
url http://dx.doi.org/10.1155/2019/3451461
work_keys_str_mv AT ornaernst thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT yifatglucksamgalnoy thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT muhammadathamna thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT irisbendror thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT hadarbenarosh thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT galitlevyrimler thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT iaindcfraser thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT tsaffrirzor thecamppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT ornaernst camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT yifatglucksamgalnoy camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT muhammadathamna camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT irisbendror camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT hadarbenarosh camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT galitlevyrimler camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT iaindcfraser camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages
AT tsaffrirzor camppathwayamplifiesearlymyd88dependentandtypeiinterferonindependentlpsinducedinterleukin10expressioninmousemacrophages